首页 | 本学科首页   官方微博 | 高级检索  
     


Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy
Authors:Rudolf A. Werner  Harun Ilhan  Sebastian Lehner  László Papp  Norbert Zsótér  Imke Schatka  Dirk O. Muegge  Mehrbod S. Javadi  Takahiro Higuchi  Andreas K. Buck  Peter Bartenstein  Frank Bengel  Markus Essler  Constantin Lapa  Ralph A. Bundschuh
Affiliation:1.The Russell H. Morgan Department of Radiology and Radiological Science, Division of Nuclear Medicine and Molecular Imaging,Johns Hopkins University School of Medicine,Baltimore,USA;2.Department of Nuclear Medicine,University Hospital Würzburg,Würzburg,Germany;3.Department of Nuclear Medicine,University Hospital, LMU Munich,Munich,Germany;4.Ambulatory Healthcare Center Dr. Neumaier & Colleagues, Radiology, Nuclear Medicine, Radiation Therapy,Regensburg,Germany;5.Department of Nuclear Medicine,Medical University of Vienna,Vienna,Austria;6.Mediso Medical Imaging Systems Ltd.,Budapest,Hungary;7.Department of Nuclear Medicine,Charité – Universit?tsmedizin Berlin,Berlin,Germany;8.Department of Bio Medical Imaging,National Cardiovascular and Cerebral Research Center,Suita,Japan;9.Department of Nuclear Medicine,Hannover Medical School,Hannover,Germany;10.Department of Nuclear Medicine,University Hospital Bonn,Bonn,Germany
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号